Kimia Biosciences Limited at its board meeting held on May 30, 2022 appointed Mr. Sameer Goel as Chief Executive Officer of the Company. Mr. Sameer Goel holds a tall stature in the Indian API market with more than 23 years of experience and has strong multi-dimensional capabilities in the areas of Business Development, Product Development, Strategic Marketing and Operations Management.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.99 INR | -0.31% | -3.72% | +41.28% |
1st Jan change | Capi. | |
---|---|---|
+41.28% | 29.52M | |
+54.64% | 811B | |
+43.62% | 640B | |
-6.58% | 353B | |
+18.37% | 333B | |
+9.24% | 302B | |
+16.89% | 246B | |
+2.49% | 225B | |
+12.64% | 218B | |
+9.13% | 168B |
- Stock Market
- Equities
- KIMIABL Stock
- News Kimia Biosciences Limited
- Kimia Biosciences Limited Appoints Sameer Goel as Chief Executive Officer